Literature DB >> 22626534

Fatal outcomes of pediatric patients with moyamoya disease associated with pulmonary arterial hypertension. Report of two cases.

Koji Tokunaga1, Tomohito Hishikawa, Kenji Sugiu, Isao Date.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22626534     DOI： 10.1016/j.clineuro.2012.05.002

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN： 0303-8467            Impact factor:   1.876


× No keyword cloud information.
  4 in total

1.  Rare variants in RNF213, a susceptibility gene for moyamoya disease, are found in patients with pulmonary hypertension and aggravate hypoxia-induced pulmonary hypertension in mice.

Authors:  Hatasu Kobayashi; Risako Kabata; Hideyuki Kinoshita; Takaaki Morimoto; Koh Ono; Midori Takeda; Jungmi Choi; Hiroko Okuda; Wanyang Liu; Kouji H Harada; Takeshi Kimura; Shohab Youssefian; Akio Koizumi
Journal:  Pulm Circ       Date:  2018-05-02       Impact factor: 3.017

2.  A histopathological report of a 16-year-old male with peripheral pulmonary artery stenosis and Moyamoya disease with a homozygous RNF213 mutation.

Authors:  Kei Takahashi; Junichi Nakamura; Shinya Sakiyama; Toshitaka Nakaya; Takahiro Sato; Taku Watanabe; Hiroshi Ohira; Keishi Makita; Utano Tomaru; Akihiro Ishizu; Ichizo Tsujino
Journal:  Respir Med Case Rep       Date:  2019-12-14

Review 3.  Ring Finger Protein 213 in Moyamoya Disease With Pulmonary Arterial Hypertension: A Mini-Review.

Authors:  Yuting Luo; Zhixin Cao; Shaoqing Wu; Xunsha Sun
Journal:  Front Neurol       Date:  2022-03-24       Impact factor: 4.003

4.  Atypical presentation of moyamoya disease with pulmonary hypertension: A case report.

Authors:  Mete Han Kızılkaya; Fahrettin Uysal; Emre Gürbüz; Mevlüt Özgür Taşkapılıoğlu; Özlem Mehtap Bostan
Journal:  Anatol J Cardiol       Date:  2018-05       Impact factor: 1.596
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.